Neuropsychiatry 
Malaysia
Home
About Us
  • About us
  • Services
  • Experts
  • Media/Gallery
NEURON 2026
  • NEURON 2026
  • Day 1 2026
  • Day 2 2026
  • Speakers 2026
  • Poster Presentation 2026
  • Local Attractions 2026
  • Committee Members 2026
Neuropsychpedia
Upcoming events
Private Chamber
Educational Activities
  • CME
  • Resources
NEURON 2025
  • NEURON 2025
  • ABSTRACT
  • Poster Presentation
  • Committee members
  • Workshop
  • Day1
  • Day2
  • Attractions
Neuropsychiatry 
Malaysia
Home
About Us
  • About us
  • Services
  • Experts
  • Media/Gallery
NEURON 2026
  • NEURON 2026
  • Day 1 2026
  • Day 2 2026
  • Speakers 2026
  • Poster Presentation 2026
  • Local Attractions 2026
  • Committee Members 2026
Neuropsychpedia
Upcoming events
Private Chamber
Educational Activities
  • CME
  • Resources
NEURON 2025
  • NEURON 2025
  • ABSTRACT
  • Poster Presentation
  • Committee members
  • Workshop
  • Day1
  • Day2
  • Attractions
More
  • Home
  • About Us
    • About us
    • Services
    • Experts
    • Media/Gallery
  • NEURON 2026
    • NEURON 2026
    • Day 1 2026
    • Day 2 2026
    • Speakers 2026
    • Poster Presentation 2026
    • Local Attractions 2026
    • Committee Members 2026
  • Neuropsychpedia
  • Upcoming events
  • Private Chamber
  • Educational Activities
    • CME
    • Resources
  • NEURON 2025
    • NEURON 2025
    • ABSTRACT
    • Poster Presentation
    • Committee members
    • Workshop
    • Day1
    • Day2
    • Attractions
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • About Us
    • About us
    • Services
    • Experts
    • Media/Gallery
  • NEURON 2026
    • NEURON 2026
    • Day 1 2026
    • Day 2 2026
    • Speakers 2026
    • Poster Presentation 2026
    • Local Attractions 2026
    • Committee Members 2026
  • Neuropsychpedia
  • Upcoming events
  • Private Chamber
  • Educational Activities
    • CME
    • Resources
  • NEURON 2025
    • NEURON 2025
    • ABSTRACT
    • Poster Presentation
    • Committee members
    • Workshop
    • Day1
    • Day2
    • Attractions

Account

  • My Account
  • Sign out

  • Sign In
  • My Account

videos/pictures 2

AkaTHISIA

Contributed by 

Siti Nor Fadhlina binti Misron

Video

Check out this great video

Akathisia

Akathisia is one of the known extrapyramidal side effect from the administration of antipsychotic. The person affected will experience the feeling of inner reslessness and/or motor restlessness.

During cross-tapering between 2 antipsychotics, the risk increases as the former antipsychotic has not completely eliminated yet the next antipsychotic already introduced.


Pathophysiology

The pathophysiology still remains at hypothesis level. The symptoms are real but the medical advancement and knowledge till this date has not yet able to decipher this puzzle. Based on the current stage of evidence, it can be hypothesised that  akathisia resulted from the imbalance of both dopaminergic and noradrenergic pathway (1). These two pathways are interconnected as they share same precursor which is tyrosine. Dopamine in the presynaptic neuron can be converted to norepinephrine by the act of dopamine beta-hydroxylase (2). 


Management

The Maudsley Prescribing Guideline has beautifully illustrates it in diagram under the topic 'Akathisia' (3). 

  

Listed are several options for management of akathisia. However, a clinician has to keep in mind that the management chosen should be specifically individualized to the patient's condition.

1. Reduce the dose of the offending antipsychotic

2. Switch to antipsychotic with lower risk of akathisia

3. Pharmacological intervention:

· Propranolol 

· Mirtazapine

· Trazodone

· Mianserin

· Animuscarinic drugs e.g. Benzhexol

· Cyproheptadine

· Benzodiazepine e.g. Clonazepam

· Clonidine


References

1. Zareifopoulos, N., Katsaraki, M., Stratos, P., Villiotou, V., Skaltsa, M., Dimitriou, A., Karveli, M., Efthimiou, P., Lagadinou, M., & Velissaris, D. (2021). Pathophysiology and management of akathisia 70 years after the introduction of the chlorpromazine, the first antipsychotic. European Review for Medical and Pharmacological Sciences, 25, 4746–4756.

2. Malhi, G. S., Malhi, S., & Mitchell, A. J. (2005). Examination notes in psychiatry: Basic sciences (2nd ed.). CRC Press.

3. Taylor, D. M., Barnes, T. R. E., & Young, A. H. (Eds.). (2025). The Maudsley prescribing guidelines in psychiatry (15th ed.). Wiley Blackwell.


PUBLISHED ON 01/12/2025

  • Home
  • About us
  • Services
  • Experts
  • Media/Gallery

Neuropsychiatry Malaysia ©

Copyright © 2026 Neuropsychiatry Malaysia - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept